HUNTINGTON NATIONAL BANK - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 4 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2023$010.0%0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$01
-99.5%
0.00%
Q4 2016$02000.0%0.00%
Q3 2016$0
-100.0%
200
-99.3%
0.00%
Q2 2016$10,00027,200
+13500.0%
0.00%
Q1 2016$02000.0%0.00%
Q4 2015$02000.0%0.00%
Q3 2015$0
-100.0%
2000.0%0.00%
Q2 2015$1,0002000.0%0.00%
Q1 2015$02000.0%0.00%
Q4 2014$02000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2019
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders